Immunohistochemistry Market to Reach US$ 3,347.57 Mn at a CAGR of 7.3% in 2027 | The Insight Partners

Immunohistochemistry Market to 2027 - Global Analysis and Forecasts By Application (Diagnostics, Drug Testing); Product (Antibodies, Equipment, Reagents, Kits); End User (Hospitals and Diagnostic Laboratories, Research Institutes, Others) and Geography

Publication Month: Oct 2019 | Report Code: TIPRE00006184 | No. of Pages: 226 | Category: Biotechnology | Status: Published

The global Immunohistochemistry market is expected to reach US$ 3,347.57 Mn in 2027 from US$ 1,787.45 in 2018. The market for immunohistochemistry is estimated to grow with a CAGR of 7.3% from 2019-2027.

During 2018, the region of North America held a maximum share in the immunohistochemistry market, generating a revenue of US$ 806.34 Mn, which is anticipated to reach up to US$ 1,536.87 Mn by the end of 2027. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technological advancements in the diagnosis industry is likely to stimulate the growth of immunohistochemistry market in North America.

 

Exhibit: Lucrative Regional Immunohistochemistry Markets



Market Insights

Rising incidences of chronic and infectious diseases

 

Immunohistochemistry (IHC) refers to an important application monoclonal and polyclonal antibodies for tissue determination and distribution of antigens of particular disease. The applications for immunohistochemistry includes detection several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Chronic medical conditions such as cancer, obesity, diabetes, heart disease, and stroke, are also considered to be the primary major applications of immunohistochemistry that helps in the diagnosis of these diseases. Increasing incidences of infectious diseases such as HIV is the primary global public health issue. In 2018, the World Health Organization (WHO) having claimed that more than 32 million HIV people to be diagnosed, out of which 770,000 people died. At the end of 2018, around 1.7 million people were reported to be newly infected globally, including 62% of adults and 54% of children. According to the HIV and AIDS organization (AVERT), in 2018, 1.1 million U.S. residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. According to the European CDC, ~2 million people in Europe were infected with HIV in 2018. Moreover, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the U.S. Similarly, in China, as per the data revealed by WHO, ~4.3 million new cases of cancer were detected as well as 2.9 million cancer deaths were recorded in 2018. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests around the world.

 

Opportunity for development in emerging nations

The emerging markets in the countries of Asia Pacific are creating significant opportunities for the key market players to expand their business. It is likely to be a prime factor contributing to the market growth during the coming years. Majority of the players concentrate on developing markets such as India and China, owing to the large population suffering from chronic diseases in these countries. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry and geographic scope. Advancements in biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of a more significant number of immunoassay systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in a developing nation.

 

Product Insights

The global immunohistochemistry market, based on product, has been segmented into antibodies, equipment, reagents, and kits. The antibodies segment held a largest share of the market in 2018. Moreover, the reagent segment is anticipated to register the highest CAGR in the market during the forecast period, since they form an essential component of any reaction and can be chosen as per the result to be obtained.

 

Exhibit: Immunohistochemistry Market, by Product

 

Strategic Insights

Growth strategies through several organic and inorganic such as approvals, product launches agreements, and partnerships have been witnessed in the market of immunohistochemistry. For instance, in May 2019, Roche launched the VENTANA pan-TRK (EPR17341) Assay, the first automated in vitro diagnostic (IVD) immunohistochemistry (IHC) assay to detect tropomyosin receptor kinase (TRK) proteins in cancer. 

Also, during January 2018, Abcam plc has signed an agreement with Roche to expand its business.


IMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION

 BY PRODUCT

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarray Systems
    • Slide Scanners
    • Other Equipment
  • Reagents
    • Histological Stains
    • Blocking and Fixation Reagents
    • Chromogenic Substrates
    • Stabilizers
    • Solvents
    • Proteolytic Enzymes
  • Kits

 

BY APPLICATION

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

 

BY END USER

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

 

BY GEOGRAPHY

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

Company Profiles

  • Danaher
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • Abcam Plc
  • Agilent Technologies
  • Bio SB
  • Bio-Rad Laboratories, Inc
  • Cell Signalling Technology, Inc.
  • F. Hoffmann-La Roche Ltd.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Immunohistochemistry Market – By Application

1.3.2        Global Immunohistochemistry Market – By Product

1.3.3        Global Immunohistochemistry Market – By End User

1.3.4        Global Immunohistochemistry Market – By Geography

2.             Global Immunohistochemistry Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Immunohistochemistry Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        Immunohistochemistry Market - North America PEST Analysis

4.2.2        Immunohistochemistry Market - Europe PEST Analysis

4.2.3        Immunohistochemistry Market – Asia Pacific PEST Analysis

4.2.4        Immunohistochemistry Market – Middle East & Africa PEST Analysis

4.2.5        Immunohistochemistry Market – South and Central America PEST Analysis

5.             Global Immunohistochemistry Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Rising Incidences of Chronic and Infectious Diseases

5.1.2        Increasing Geriatric Population

5.1.3        Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2       Key Market Restraints

5.2.1        Limitations Associated with Immunohistochemistry

5.3       Key Market Opportunities

5.3.1        Development Opportunities in Emerging Countries

5.4       Future Trends

5.4.1        Increasing Acceptance of Automation in Immunohistochemistry

5.5       Impact Analysis

6.             Immunohistochemistry Market – Global Analysis

6.1       Global Immunohistochemistry Market Revenue Forecasts And Analysis

6.2       Global Immunohistochemistry Market, By Geography - Forecasts And Analysis

6.3       Performance of Key Players

7.             Immunohistochemistry Market Revenue And Forecasts To 2027 – Application

7.1       Overview

7.2       Global Immunohistochemistry Market Share by Application 2018 & 2027 (%)

7.3       Diagnostics

7.3.1        Overview

7.3.2        Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

7.3.3        Cancer

7.3.3.1      Overview

7.3.3.2      Cancer Market Revenue and Forecast to 2027 (US$ Mn)

7.3.4        Infectious Diseases

7.3.4.1      Overview

7.3.4.2      Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.3.5        Autoimmune Diseases

7.3.5.1      Overview

7.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.3.6        Nephrological Diseases

7.3.6.1      Overview

7.3.6.2      Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Drug Testing

7.4.1        Overview

7.4.2        Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)

8.             Global Immunohistochemistry Market Revenue And Forecasts To 2027 – by Product

8.1       Overview

8.2       Global Immunohistochemistry Market, By Product 2018 & 2027 (%)

8.3       Antibodies Market

8.3.1        Overview

8.3.2        Global Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.3        Primary Antibodies Market

8.3.3.1      Overview

8.3.3.2      Global Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.4        Secondary Antibodies Market

8.3.4.1      Overview

8.3.4.2      Global Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Equipment Market

8.4.1        Overview

8.4.2        Global Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.3        Slide Staining Systems Market

8.4.3.1      Overview

8.4.3.2      Global Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4        Tissue Microarrays Market

8.4.4.1      Overview

8.4.4.2      Global Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.5        Slide Scanners Market

8.4.5.1      Overview

8.4.5.2      Global Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.6        Other Equipment Market

8.4.6.1      Overview

8.4.6.2      Global Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

8.5       Reagents Market

8.5.1        Overview

8.5.2        Global Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.3        Histological Stains Market

8.5.3.1      Overview

8.5.3.2      Global Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4        Blocking & Fixation Reagents Market

8.5.4.1      Overview

8.5.4.2      Global Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.5        Chromogenic Substrates Market

8.5.5.1      Overview

8.5.5.2      Global Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.6        Stabilizers Market

8.5.6.1      Overview

8.5.6.2      Global Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.7        Proteolytic Enzymes Market

8.5.7.1      Overview

8.5.7.2      Global Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.8        Solvents Market

8.5.8.1      Overview

8.5.8.2      Global Solvents Market Revenue and Forecasts to 2027 (US$ Mn)

8.6       Kits Market

8.6.1        Overview

8.6.2        Global Kits Market Revenue and Forecasts to 2027 (US$ Mn)

9.             Global Immunohistochemistry Market Revenue And Forecasts To 2027 – by End User

9.1       Overview

9.2       Global Immunohistochemistry Market, By End User 2018 & 2027 (%)

9.3       Hospital & Diagnostic Laboratories Market

9.3.1        Overview

9.3.2        Global Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9.4       Research Institutes Market

9.4.1        Overview

9.4.2        Global Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

9.5       Others Market

9.5.1        Overview

9.5.2        Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.          Immunohistochemistry Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1    North America Immunohistochemistry Market Revenue And Forecasts To 2027

10.1.1     North America Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.2     North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.2.1    North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3     North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.3.1    North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.2    North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.3    North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.4     North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.5     North America Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

10.1.6     US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1    US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2    US Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.6.2.1    US Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3    US Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.6.3.1    US Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3.2    US Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3.3    US Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.4    US Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.7     Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1    Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2    Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.7.2.1    Canada Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3    Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.7.3.1    Canada Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3.2    Canada Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3.3    Canada Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.4    Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.8     Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1    Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2    Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.8.2.1    Mexico Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3    Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.8.3.1    Mexico Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3.2    Mexico Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3.3    Mexico Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.4    Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2    Europe Immunohistochemistry Market Revenue And Forecasts To 2027

10.2.1     Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.2     Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.2.1    Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.3     Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.3.1    Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.3.2    Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.3.3    Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.4     Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.5     Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

10.2.6     UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.1    UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.2    UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.6.2.1    UK Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.6.3    UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.6.3.1    UK Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.6.3.2    UK Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.6.3.3    UK Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.6.4    UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.7     Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.1    Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.2    Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.7.2.1    Germany Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.7.3    Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.7.3.1    Germany Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.7.3.2    Germany Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.7.3.3    Germany Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.7.4    Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.8     France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.1    France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.2    France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.8.2.1    France Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.8.3    France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.8.3.1    France Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.8.3.2    France Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.8.3.3    France Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.8.4    France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.9     Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.1    Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.2    Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.9.2.1    Italy Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.9.3    Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.9.3.1    Italy Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.9.3.2    Italy Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.9.3.3    Italy Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.9.4    Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.10   Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.2 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.2.10.2.1 Spain Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.10.3 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.10.3.1 Spain Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.10.3.2 Spain Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.10.3.3 Spain Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.2.10.4 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3    Asia Pacific Immunohistochemistry Market Revenue And Forecasts To 2027

10.4    Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.1     Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.1.1    Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.2     Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.2.1    Asia Pacific Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.2.2    Asia Pacific Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.2.3    Asia Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.3     Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.4     Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

10.4.5     Japan Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.5.1    Japan Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.5.2    Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.5.2.1    Japan Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.5.3    Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.5.3.1    Japan Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.5.3.2    Japan Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.5.3.3    Japan Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.5.4    Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.6     China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.6.1    China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.6.2    China Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.6.2.1    China Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.6.3    China Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.6.3.1    China Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.6.3.2    China Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.6.3.3    China Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.6.4    China Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.7     India Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.1    India Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.2    India Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.7.2.1    India Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.7.3    India Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.7.3.1    India Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.7.3.2    India Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.7.3.3    India Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.7.4    India Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.8     South Korea Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8.1    South Korea Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8.2    South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.8.2.1    South Korea Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.8.3    South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.8.3.1    South Korea Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.8.3.2    South Korea Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.8.3.3    South Korea Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.8.4    South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.9     Australia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.9.1    Australia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.9.2    Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.4.9.2.1    Australia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.9.3    Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.9.3.1    Australia Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.9.3.2    Australia Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.9.3.3    Australia Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.4.9.4    Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5    Middle East & Africa Immunohistochemistry Market Revenue And Forecasts To 2027

10.5.1     Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.2     Middle East & Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By Application  (US$ Mn)

10.5.2.1    Middle East & Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.3     Middle East & Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By Product  (US$ Mn)

10.5.3.1    Middle East & Africa Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.3.2    Middle East & Africa Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.3.3    Middle East & Africa Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.4     Middle East & Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By End User  (US$ Mn)

10.5.5     Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

10.5.6     UAE Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6.1    UAE Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6.2    UAE Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.5.6.2.1    UAE Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.6.3    UAE Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.6.3.1    UAE Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.6.3.2    UAE Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.6.3.3    UAE Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.6.4    UAE Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.7     Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.1    Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.2    Saudi Arabia Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.5.7.2.1    Saudi Arabia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.7.3    Saudi Arabia Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.7.3.1    Saudi Arabia Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.7.3.2    Saudi Arabia Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.7.3.3    Saudi Arabia Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.7.4    Saudi Arabia Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.8     South Africa Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.8.1    South Africa Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.8.2    South Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.5.8.2.1    South Africa Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.8.3    South Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.8.3.1    South Africa Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.8.3.2    South Africa Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.8.3.3    South Africa Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.5.8.4    South Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.6    South And Central America Immunohistochemistry Market Revenue And Forecasts To 2027

10.6.1     South and Central America Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.2     South and Central America Immunohistochemistry Market Revenue And Forecasts to 2027,  By Application (US$ Mn)

10.6.2.1    South and Central America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.3     South and Central America Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.3.1    South and Central America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.3.2    South and Central America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.3.3    South and Central America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.4     South and Central America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.6.5     South and Central America Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

10.6.6     Argentina Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.6.1    Argentina Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.6.2    Argentina Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.6.6.2.1    Argentina Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.6.6.3    Argentina Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.6.3.1    Argentina Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.6.6.3.2    Argentina Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.6.6.3.3    Argentina Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.6.6.4    Argentina Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.6.7     Brazil Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.7.1    Brazil Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.7.2    Brazil Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.6.7.2.1    Brazil Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.6.7.3    Brazil Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.7.3.1    Brazil Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.6.7.3.2    Brazil Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.6.7.3.3    Brazil Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.6.7.4    Brazil Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.          Immunohistochemistry Market – Industry Landscape

11.1    Overview

11.2    Growth Strategies done by the companies in the Market, 2018 (%)

11.3    Organic Developments

11.3.1     Overview

11.4    Inorganic developments

11.4.1     Overview

12.          Immunohistochemistry Market–Key Company Profiles

12.1    Bio SB

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Financial Overview

12.1.4     Product portfolio

12.1.5     SWOT ANALYSIS

12.1.6     Key Developments

12.2    Cell Signaling Technology, Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Financial Overview

12.2.4     Product portfolio

12.2.5     SWOT ANALYSIS

12.2.6     Key Developments

12.3    F. Hoffmann-La Roche Ltd.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Financial Overview

12.3.4     Product Portfolio

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Merck KGaA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Financial Overview

12.4.4     Product Portfolio

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    PerkinElmer, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Financial Overview

12.5.4     Product Portfolio

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Thermo Fisher Scientific, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Financial Overview

12.6.4     Product Portfolio

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Abcam Plc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Financial Overview

12.7.4     Product Portfolio

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Agilent Technologies, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Financial Overview

12.8.4     Product Portfolio

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Bio-Rad Laboratories, Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Financial Information

12.9.4     Product Portfolio

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Danaher

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Financial Information

12.10.4   Product Portfolio

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.          Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms


LIST OF TABLES

Table 1.            R&D Investments by Major Biopharmaceutical Companies

Table 2.            North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 3.            North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 4.            North America Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 5.            North America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 6.            North America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 7.            North America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 8.            North America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 9.            US Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 10.         US Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 11.         US Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 12.         US Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 13.         US Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 14.         US Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 15.         US Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 16.         Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 17.         Canada Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 18.         Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 19.         Canada Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 20.         Canada Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 21.         Canada Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 22.         Canada Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 23.         Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 24.         Mexico Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 25.         Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 26.         Mexico Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 27.         Mexico Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 28.         Mexico Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 29.         Mexico Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 30.         Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 31.         Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 32.         Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 33.         Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 34.         Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 35.         Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 36.         Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 37.         UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 38.         UK Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 39.         UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 40.         UK Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 41.         UK Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 42.         UK Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 43.         UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 44.         Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 45.         Germany Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 46.         Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 47.         Germany Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 48.         Germany Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 49.         Germany Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 50.         Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 51.         France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 52.         France Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 53.         France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 54.         France Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 55.         France Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 56.         France Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 57.         France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 58.         Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 59.         Italy Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 60.         Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 61.         Italy Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 62.         Italy Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 63.         Italy Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 64.         Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 65.         Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 66.         Spain Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 67.         Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 68.         Spain Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 69.         Spain Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 70.         Spain Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 71.         Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 72.         Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 73.         Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 74.         Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 75.         Asia Pacific Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 76.         Asia Pacific Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 77.         Asia Pacific Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 78.         Asia Pacific Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 79.         Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 80.         Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 81.         Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 82.         Japan Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 83.         Japan Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 84.         Japan Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 85.         Japan Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 86.         China Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 87.         China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 88.         China Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 89.         China Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 90.         China Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 91.         China Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 92.         China Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 93.         India Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 94.         India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 95.         India Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 96.         India Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 97.         India Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 98.         India Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 99.         India Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 100.       South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 101.       South Korea Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 102.       South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 103.       South Korea Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 104.       South Korea Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 105.       South Korea Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 106.       South Korea Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 107.       Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 108.       Australia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 109.       Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 110.       Australia Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 111.       Australia Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 112.       Australia Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 113.       Australia Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 114.       Middle East & Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 115.       Middle East & Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 116.       Middle East & Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 117.       Middle East & Africa Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 118.       Middle East & Africa Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 119.       Middle East & Africa Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 120.       Middle East & Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 121.       UAE Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 122.       UAE Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 123.       UAE Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 124.       UAE Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 125.       UAE Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 126.       UAE Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 127.       UAE Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 128.       Saudi Arabia Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 129.       Saudi Arabia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 130.       Saudi Arabia Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 131.       Saudi Arabia Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 132.       Saudi Arabia Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 133.       Saudi Arabia Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 134.       Saudi Arabia Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 135.       South Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 136.       South Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 137.       South Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 138.       South Africa Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 139.       South Africa Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 140.       South Africa Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 141.       South Africa Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 142.       South and Central America Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 143.       South and Central America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 144.       South and Central America Immunohistochemistry Market Revenue And Forecasts to 2027, By Product  (US$ Mn)

Table 145.       South and Central America Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 146.       South and Central America Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 147.       South and Central America Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 148.       South and Central America Immunohistochemistry Market Revenue And Forecasts to 2027, By End User  (US$ Mn)

Table 149.       Argentina Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 150.       Argentina Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 151.       Argentina Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 152.       Argentina Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 153.       Argentina Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 154.       Argentina Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 155.       Argentina Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 156.       Brazil Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 157.       Brazil Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 158.       Brazil Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 159.       Brazil Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 160.       Brazil Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 161.       Brazil Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 162.       Brazil Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 163.       Organic Developments Done By Companies

Table 164.       Inorganic developments done by Companies

Table 165.       Glossary of Terms, Immunohistochemistry Market

 

LIST OF FIGURES

Figure 1.          Immunohistochemistry Market Segmentation

Figure 2.          Immunohistochemistry Market Segmentation, by Region

Figure 3.          Global Immunohistochemistry Market Overview

Figure 4.          Reagents & Kits Segment Held Largest Share Of The Product Segment In Immunohistochemistry Market

Figure 5.          Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period

Figure 6.          Global Immunohistochemistry Market, By Geography (US$ Mn)

Figure 7.          Global Immunohistochemistry Market- Leading Country Markets (US$ Mn)

Figure 8.          Global Immunohistochemistry Market, Industry Landscape

Figure 9.          Immunohistochemistry Market - North America PEST Analysis

Figure 10.       Immunohistochemistry Market - Europe Pest Analysis

Figure 11.       Immunohistochemistry Market – Asia Pacific Pest Analysis

Figure 12.       Immunohistochemistry Market – Middle East & Africa Pest Analysis

Figure 13.       Immunohistochemistry Market – South and Central America PEST Analysis

Figure 14.       Impact Analysis of Drivers and Restraints Pertaining to Immunoassay Market

Figure 15.       Global Immunohistochemistry Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 16.       Global Immunohistochemistry Market – by Geography Forecasts and Analysis – 2018- 2027

Figure 17.       Prominent Players in the Immunohistochemistry Market

Figure 18.       Global Immunohistochemistry Market Share by Application 2018 & 2027 (%)

Figure 19.       Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Cancer Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       Infectious Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       Autoimmune Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       Nephrological Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Drug Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Global Immunohistochemistry Market, by Product 2018 & 2027 (%)

Figure 26.       Global Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.       Global Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.       Global Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.       Global Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.       Global Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.       Global Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32.       Global Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.       Global Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34.       Global Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.       Global Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36.       Global Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.       Global Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.       Global Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39.       Global Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.       Global Solvents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.       Global Kits Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42.       Global Immunohistochemistry Market, by End User 2018 & 2027 (%)

Figure 43.       Global Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 44.       Global Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.       Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 46.       North America Immunohistochemistry Market Revenue Overview, by Country (2018) (US$ Mn)

Figure 47.       North America Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48.       North America Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

Figure 49.       US Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 50.       Canada Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.       Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 52.       Europe Immunohistochemistry Market Overview, by Country (2018)

Figure 53.       Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 54.       Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

Figure 55.       UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 56.       Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57.       France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 58.       Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59.       Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 60.       Asia Pacific Immunohistochemistry Market Overview, by Country (2018)

Figure 61.       Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 62.       Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

Figure 63.       Japan Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 64.       China Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 65.       India Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 66.       South Korea Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 67.       Australia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 68.       Middle East & Africa Immunohistochemistry Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 69.       Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 70.       Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

Figure 71.       UAE Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 72.       Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 73.       South Africa Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 74.       South and Central America Immunohistochemistry Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 75.       South and Central America Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 76.       South and Central America Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

Figure 77.       Argentina Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 78.       Brazil Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 79.       Growth Strategies done by the companies in the Market, 2018 (%)

 

The List of Companies

  1. Danaher
  2. Merck KGaA
  3. Thermo Fisher Scientific, Inc.
  4. PerkinElmer, Inc.
  5. Abcam Plc
  6. Agilent Technologies
  7. Bio SB
  8. Bio-Rad Laboratories, Inc
  9. Cell Signalling Technology, Inc.
  10. F. Hoffmann-La Roche Ltd.
  • Save and reduce time carrying out entrylevel research by identifying the growth, size, leading players and segments in the immunohistochemistry market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global immunohistochemistry market, thereby allowing players across the value chain to develop effective longterm strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize indepth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decisionmaking process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.